Barely Significant
← all excerpts

8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial.

Breast Cancer Res · 2025 · PMC12057130 · PMID 40329331

1
hedged sentence
closest p
boldest claim

The sentences

may not be significantno p-value reported
Although the correlation between chemotherapy-induced neutropenia and tumor type may not be significant, this study has certain limitations, as it included only the Chinese breast cancer population.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.